Belinda H McCully1, Christopher R Connelly2, Kelly A Fair2, John B Holcomb3, Erin E Fox3, Charles E Wade3, Eileen M Bulger4, Martin A Schreiber2. 1. Division of Trauma, Critical Care and Acute Care Surgery, Department of Surgery, Oregon Health & Science University, Portland, OR. Electronic address: houghtob@ohsu.edu. 2. Division of Trauma, Critical Care and Acute Care Surgery, Department of Surgery, Oregon Health & Science University, Portland, OR. 3. Center for Translational Injury Research, Division of Acute Care Surgery, Department of Surgery, University of Texas Health Science Center, Houston, TX. 4. Division of Trauma and Critical Care, Department of Surgery, University of Washington, Seattle, WA.
Abstract
BACKGROUND: Altered coagulation function after trauma can contribute to development of venous thromboembolism (VTE). Severe trauma impairs coagulation function, but the trajectory for recovery is not known. We hypothesized that enhanced, early recovery of coagulation function increases VTE risk in severely injured trauma patients. STUDY DESIGN: Secondary analysis was performed on data from the Pragmatic Randomized Optimal Platelet and Plasma Ratio (PROPPR) trial, excluding patients who died within 24 hours or were on pre-injury anticoagulants. Patient characteristics, adverse outcomes, and parameters of platelet function and coagulation (thromboelastography) were compared from admission to 72 hours between VTE (n = 83) and non-VTE (n = 475) patients. A p value < 0.05 indicates significance. RESULTS: Despite similar patient demographics, VTE patients exhibited hypercoagulable thromboelastography parameters and enhanced platelet function at admission (p < 0.05). Both groups exhibited hypocoagulable thromboelastography parameters, platelet dysfunction, and suppressed clot lysis (low clot lysis at 30 minutes) 2 hours after admission (p < 0.05). The VTE patients exhibited delayed coagulation recovery (a significant change compared with 2 hours) of K-value (48 vs 24 hours), α-angle (no recovery), maximum amplitude (24 vs 12 hours), and clot lysis at 30 minutes (48 vs 12 hours). Platelet function recovery mediated by arachidonic acid (72 vs 4 hours), ADP (72 vs 12 hours), and collagen (48 vs 12 hours) was delayed in VTE patients. The VTE patients had lower mortality (4% vs 13%; p < 0.05), but fewer hospital-free days (0 days [interquartile range 0 to 8 days] vs 10 days [interquartile range 0 to 20 days]; p < 0.05) and higher complication rates (p < 0.05). CONCLUSIONS: Recovery from platelet dysfunction and coagulopathy after severe trauma were delayed in VTE patients. Suppressed clot lysis and compensatory mechanisms associated with altered coagulation that can potentiate VTE formation require additional investigation.
RCT Entities:
BACKGROUND: Altered coagulation function after trauma can contribute to development of venous thromboembolism (VTE). Severe trauma impairs coagulation function, but the trajectory for recovery is not known. We hypothesized that enhanced, early recovery of coagulation function increases VTE risk in severely injured traumapatients. STUDY DESIGN: Secondary analysis was performed on data from the Pragmatic Randomized Optimal Platelet and Plasma Ratio (PROPPR) trial, excluding patients who died within 24 hours or were on pre-injury anticoagulants. Patient characteristics, adverse outcomes, and parameters of platelet function and coagulation (thromboelastography) were compared from admission to 72 hours between VTE (n = 83) and non-VTE (n = 475) patients. A p value < 0.05 indicates significance. RESULTS: Despite similar patient demographics, VTEpatients exhibited hypercoagulable thromboelastography parameters and enhanced platelet function at admission (p < 0.05). Both groups exhibited hypocoagulable thromboelastography parameters, platelet dysfunction, and suppressed clot lysis (low clot lysis at 30 minutes) 2 hours after admission (p < 0.05). The VTEpatients exhibited delayed coagulation recovery (a significant change compared with 2 hours) of K-value (48 vs 24 hours), α-angle (no recovery), maximum amplitude (24 vs 12 hours), and clot lysis at 30 minutes (48 vs 12 hours). Platelet function recovery mediated by arachidonic acid (72 vs 4 hours), ADP (72 vs 12 hours), and collagen (48 vs 12 hours) was delayed in VTEpatients. The VTEpatients had lower mortality (4% vs 13%; p < 0.05), but fewer hospital-free days (0 days [interquartile range 0 to 8 days] vs 10 days [interquartile range 0 to 20 days]; p < 0.05) and higher complication rates (p < 0.05). CONCLUSIONS: Recovery from platelet dysfunction and coagulopathy after severe trauma were delayed in VTEpatients. Suppressed clot lysis and compensatory mechanisms associated with altered coagulation that can potentiate VTE formation require additional investigation.
Authors: Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Angela Sauaia; Anirban Banerjee; Christopher C Silliman Journal: Transfusion Date: 2016-04 Impact factor: 3.157
Authors: Jeffrey N Harr; Ernest E Moore; Theresa L Chin; Arsen Ghasabyan; Eduardo Gonzalez; Max V Wohlauer; Angela Sauaia; Anirban Banerjee; Christopher C Silliman Journal: Shock Date: 2014-01 Impact factor: 3.454
Authors: Casey J Allen; Clark R Murray; Jonathan P Meizoso; Juliet J Ray; Laura F Teisch; Xiomara D Ruiz; Mena M Hanna; Gerardo A Guarch; Ronald J Manning; Alan S Livingstone; Enrique Ginzburg; Carl I Schulman; Nicholas Namias; Kenneth G Proctor Journal: Am Surg Date: 2015-07 Impact factor: 0.688
Authors: Max V Wohlauer; Ernest E Moore; Scott Thomas; Angela Sauaia; Ed Evans; Jeffrey Harr; Christopher C Silliman; Victoria Ploplis; Francis J Castellino; Mark Walsh Journal: J Am Coll Surg Date: 2012-05 Impact factor: 6.113
Authors: Bryan A Cotton; Kristin M Minei; Zayde A Radwan; Nena Matijevic; Evan Pivalizza; Jeanette Podbielski; Charles E Wade; Rosemary A Kozar; John B Holcomb Journal: J Trauma Acute Care Surg Date: 2012-06 Impact factor: 3.313
Authors: Jeffrey N Harr; Ernest E Moore; Theresa L Chin; Arsen Ghasabyan; Eduardo Gonzalez; Max V Wohlauer; Anirban Banerjee; Christopher C Silliman; Angela Sauaia Journal: J Trauma Acute Care Surg Date: 2013-03 Impact factor: 3.313
Authors: Jeffry L Kashuk; Ernest E Moore; Allison Sabel; Carlton Barnett; James Haenel; Tuan Le; Michael Pezold; Jerry Lawrence; Walter L Biffl; C Clay Cothren; Jeffrey L Johnson Journal: Surgery Date: 2009-10 Impact factor: 3.982
Authors: Jan-Michael Van Gent; Ashley L Zander; Erik J Olson; Steven R Shackford; Casey E Dunne; C Beth Sise; Jayraan Badiee; Mark S Schechter; Michael J Sise Journal: J Trauma Acute Care Surg Date: 2014-05 Impact factor: 3.313
Authors: Jessica C Cardenas; Yao-Wei Wang; Jay V Karri; Seenya Vincent; Andrew P Cap; Bryan A Cotton; Charles E Wade Journal: Thromb Res Date: 2020-01-15 Impact factor: 3.944
Authors: M Margaret Knudson; Ernest E Moore; Lucy Z Kornblith; Amy M Shui; Scott Brakenridge; Brandon R Bruns; Mark D Cipolle; Todd W Costantini; Bruce A Crookes; Elliott R Haut; Andrew J Kerwin; Laszlo N Kiraly; Lisa M Knowlton; Matthew J Martin; Michelle K McNutt; David J Milia; Alicia Mohr; Ram Nirula; Fredrick B Rogers; Thomas M Scalea; Sherry L Sixta; David A Spain; Charles E Wade; George C Velmahos Journal: JAMA Surg Date: 2022-02-09 Impact factor: 16.681
Authors: Zachary A Matthay; Zane J Hellmann; Brenda Nunez-Garcia; Alexander T Fields; Joseph Cuschieri; Matthew D Neal; Jeffrey S Berger; Elliot Luttrell-Williams; M Margaret Knudson; Mitchell J Cohen; Rachael A Callcut; Lucy Z Kornblith Journal: J Trauma Acute Care Surg Date: 2022-04-21 Impact factor: 3.697
Authors: Michael A Vella; Ryan P Dumas; Kristen Chreiman; Thomas Wasser; Brian P Smith; Patrick M Reilly; Mark J Seamon; Adam Shiroff Journal: J Thromb Thrombolysis Date: 2020-04 Impact factor: 2.300
Authors: Belinda H McCully; Charlie E Wade; Erin E Fox; Kenji Inaba; Mitchell J Cohen; John B Holcomb; Martin A Schreiber Journal: J Trauma Acute Care Surg Date: 2021-05-01 Impact factor: 3.697